망막 레이저 광응고술 시장 규모 조사 : 레이저 유형별, 적응증별, 디바이스 모달리티별, 최종사용자별, 지역별 예측(2022-2032년)

Global Retinal Laser Photocoagulation Market is valued at approximately USD 240.3 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2024-2032. The market growth is being propelled by an increasing focus on minimally invasive treatments in ophthalmology, including retinal laser photocoagulation. Compared to traditional surgical interventions, retinal laser photocoagulation offers a less invasive alternative with shorter recovery times and reduced risk of complications.

Retinal laser photocoagulation allows for targeted treatment of specific areas of the retina while preserving the surrounding healthy tissue. The laser energy is absorbed by the targeted abnormal blood vessels or retinal tissue, causing them to coagulate and seal off without affecting the nearby healthy structures. This targeted approach minimizes collateral damage and helps preserve overall retinal function. There is a growing emphasis on regular eye examinations and early detection of retinal disorders. Increased awareness among patients and healthcare professionals about the benefits of retinal laser photocoagulation for treating these conditions has contributed to market growth. Reimbursement policies and insurance coverage for retinal laser photocoagulation procedures vary by country and region. However, in many cases, reimbursement policies have become more favourable, making the procedure more affordable for patients and driving market growth. However, . high cost of specialized equipment and devices and potential risks and complications associated with the procedure would stifle the market growth.

The key regions considered for the global Retinal Laser Photocoagulation market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. The retinal laser photocoagulation industry in North America is dominating in 2023, micro pulse laser technology is gaining popularity for retinal laser photocoagulation, high prevalence of retinal disorders such as diabetic retinopathy and age-related macular degeneration. The region boasts an advanced healthcare infrastructure with well-equipped medical facilities and a high number of specialized ophthalmologists and healthcare professionals who are trained in advanced treatments. The Asia-Pacific region is the fastest-growing market for retinal laser photocoagulation. The region is experiencing a rapid increase in the prevalence of diabetes, which is a major risk factor for diabetic retinopathy, a leading condition treated with retinal laser photocoagulation. Secondly, improvements in healthcare infrastructure and increasing access to advanced medical technologies in countries such as China and India are facilitating greater adoption of retinal treatments. Additionally, rising awareness about eye health, increasing disposable incomes, and supportive government initiatives aimed at combating visual impairments are further driving the market's expansion in this region.

Major market players included in this report are:

• Alcon Laboratories, Inc.
• A.R.C Laser GmbH
• Ellex Medical Lasers Ltd.
• Carl Zeiss Meditec AG
• Quantel Medical S.A
• LightMed Corporation
• Navilas
• Norlase
• NIDEK Co. Ltd
• Ziemer Ophthalmic Systems
• IRIDEX Corporation
• Lumibird Medical
• Lumenis Be Ltd.
• Novartis AG
• Boston Scientific Corporation

The detailed segments and sub-segments of the market are explained below:

By Laser Type

• Argon Laser (488 nm)
• Green Laser (532 nm)
• Yellow Laser (577 nm)
• Diode Laser (810-1050 nm)

By Indication

• Proliferative Diabetic Retinopathy (PDR)
• Diabetic Macular Edema (DME)
• Retinal Vein Occlusion (RVO)
• Retinal Tears, Holes, and Lattice Degeneration
• Central Serous Chorioretinopathy (CSC)
• Choroidal Neovascularization
• Others Indications

By Device Modality

• Fixed Devices
• Mobile Devices

By End User

• Hospitals
• Ambulatory Surgical Centers
• Ophthalmology Clinics

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2033

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Retinal Laser Photocoagulation Market Executive Summary

• 1.1. Global Retinal Laser Photocoagulation Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Laser Type
  • 1.3.2. By Indication
  • 1.3.3. By Device Modality
  • 1.3.4. By End User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Retinal Laser Photocoagulation Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Retinal Laser Photocoagulation Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Increasing minimally invasive treatments
  • 3.1.2. Growing awareness and early detection of retinal disorders
• 3.2. Market Challenges
  • 3.2.1. High cost of specialized equipment and devices
  • 3.2.2. Potential risks and complications associated with the procedure
• 3.3. Market Opportunities
  • 3.3.1. Combination therapies
  • 3.3.2. Patient-centered care and personalized medicine
  • 3.3.3. Telemedicine and remote healthcare services

Chapter 4. Global Retinal Laser Photocoagulation Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Retinal Laser Photocoagulation Market Size & Forecasts by Laser Type 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Retinal Laser Photocoagulation Market: Laser Type Revenue Trend Analysis, 2022 & 2032(USD Million)
  • 5.2.1. Argon Laser (488 nm)
  • 5.2.2. Green Laser (532 nm)
  • 5.2.3. Yellow Laser (577 nm)
  • 5.2.4. Diode Laser (810-1050 nm)

Chapter 6. Global Retinal Laser Photocoagulation Market Size & Forecasts by Indication 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Retinal Laser Photocoagulation Market: Indication Revenue Trend Analysis, 2022 & 2032(USD Million)
  • 6.2.1. Proliferative Diabetic Retinopathy (PDR)
  • 6.2.2. Diabetic Macular Edema (DME)
  • 6.2.3. Retinal Vein Occlusion (RVO)
  • 6.2.4. Retinal Tears, Holes, and Lattice Degeneration
  • 6.2.5. Central Serous Chorioretinopathy (CSC)
  • 6.2.6. Choroidal Neovascularization
  • 6.2.7. Others Indications

Chapter 7. Global Retinal Laser Photocoagulation Market Size & Forecasts by Device Modality 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Retinal Laser Photocoagulation Market: Device Modality Revenue Trend Analysis, 2022 & 2032(USD Million)
  • 7.2.1. Fixed Devices
  • 7.2.2. Mobile Devices

Chapter 8. Global Retinal Laser Photocoagulation Market Size & Forecasts by End User 2022-2032

• 8.1. Segment Dashboard
• 8.2. Global Retinal Laser Photocoagulation Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
  • 8.2.1. Hospitals
  • 8.2.2. Ambulatory Surgical Centers
  • 8.2.3. Ophthalmology Clinics

Chapter 9. Global Retinal Laser Photocoagulation Market Size & Forecasts by Region 2022-2032

• 9.1. North America Retinal Laser Photocoagulation Market
  • 9.1.1. U.S. Retinal Laser Photocoagulation Market
    • 9.1.1.1. By Laser Type breakdown size & forecasts, 2022-2032
    • 9.1.1.2. By Indication breakdown size & forecasts, 2022-2032
    • 9.1.1.3. By Device Modality breakdown size & forecasts, 2022-2032
    • 9.1.1.4. By End User breakdown size & forecasts, 2022-2032
  • 9.1.2. Canada Retinal Laser Photocoagulation Market
• 9.2. Europe Retinal Laser Photocoagulation Market
  • 9.2.1. U.K. Retinal Laser Photocoagulation Market
  • 9.2.2. Germany Retinal Laser Photocoagulation Market
  • 9.2.3. France Retinal Laser Photocoagulation Market
  • 9.2.4. Spain Retinal Laser Photocoagulation Market
  • 9.2.5. Italy Retinal Laser Photocoagulation Market
  • 9.2.6. Rest of Europe Retinal Laser Photocoagulation Market
• 9.3. Asia-Pacific Retinal Laser Photocoagulation Market
  • 9.3.1. China Retinal Laser Photocoagulation Market
  • 9.3.2. India Retinal Laser Photocoagulation Market
  • 9.3.3. Japan Retinal Laser Photocoagulation Market
  • 9.3.4. Australia Retinal Laser Photocoagulation Market
  • 9.3.5. South Korea Retinal Laser Photocoagulation Market
  • 9.3.6. Rest of Asia Pacific Retinal Laser Photocoagulation Market
• 9.4. Latin America Retinal Laser Photocoagulation Market
  • 9.4.1. Brazil Retinal Laser Photocoagulation Market
  • 9.4.2. Mexico Retinal Laser Photocoagulation Market
  • 9.4.3. Rest of Latin America Retinal Laser Photocoagulation Market
• 9.5. Middle East & Africa Retinal Laser Photocoagulation Market
  • 9.5.1. Saudi Arabia Retinal Laser Photocoagulation Market
  • 9.5.2. South Africa Retinal Laser Photocoagulation Market
  • 9.5.3. Rest of Middle East & Africa Retinal Laser Photocoagulation Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. Alcon Laboratories, Inc.
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Market Strategies
  • 10.3.2. A.R.C Laser GmbH
  • 10.3.3. Ellex Medical Lasers Ltd.
  • 10.3.4. Carl Zeiss Meditec AG
  • 10.3.5. Quantel Medical S.A
  • 10.3.6. LightMed Corporation
  • 10.3.7. Navilas
  • 10.3.8. Norlase
  • 10.3.9. NIDEK Co. Ltd
  • 10.3.10. Ziemer Ophthalmic Systems
  • 10.3.11. IRIDEX Corporation
  • 10.3.12. Lumibird Medical
  • 10.3.13. Lumenis Be Ltd.
  • 10.3.14. Novartis AG
  • 10.3.15. Boston Scientific Corporation

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.3. Analysis
  • 11.1.4. Market Estimation
  • 11.1.5. Validation
  • 11.1.6. Publishing
• 11.2. Research Attributes